Paratek Pharma Announces Microbiology Data from Phase 3 Trial in Acute Skin Infections Found Once-Daily Treatment with IV-to-Oral Omadacycline Effective in Treating Most-Frequently Isolated Baterial Pathogens Associated with Skin Infections